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Abstract
Fast-scan cyclic voltammetry in brain slices and postmortem tissue content assessment were used
to evaluate presynaptic dopaminergic function in the caudate putamen and nucleus accumbens of
adult male rats (180+ days old) that were prenatally treated with either cocaine or saline.
Experiments were carried out to test whether there were differences in dopamine release, reuptake,
autoreceptor function or the tissue levels of dopamine and its metabolites between cocaine- and
saline-exposed rats. We report that presynaptic dopaminergic function remains largely intact in
adult rats that were prenatally exposed to cocaine. The ability of terminals in the caudate putamen
and nucleus accumbens to release and regulate dopamine is unaltered by prenatal cocaine
exposure. However the tissue content of dopamine in the caudate putamen was decreased,
representing a diminution in the dopamine storage pool. We conclude, therefore, that behavioral
changes that have previously been observed in rats that were prenatally exposed to cocaine are not
mediated through alteration of presynaptic dopaminergic mechanisms in these brain regions.
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1. Introduction
There have been a number of reports of changes in dopaminergic function in young
offspring that were exposed to cocaine in utero [3,6,15,16,23]. Behavioral abnormalities
have been correlated with some of these changes [6]. However, dopaminergic function in
adults that were prenatally exposed to cocaine has been less extensively studied. This group
is of particular interest because they express altered social and aggressive behavior
[10,11,24,34] relative to animals prenatally exposed to saline. In particular, adult male rats
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of 180 days old or more show increased aggression and were somewhat more neophobic
(reluctant to explore a novel environment) than saline-exposed controls [10].
The etiology of these effects remains unclear. Exposure to cocaine in pregnant dams induces
uterine ischemia [20] which may disrupt embryonic development of dopaminergic neurons.
In addition, cocaine has a number of other pharmacological properties that may affect the
fetus directly. These include a local anesthetic action [4] and competitive antagonism of the
plasma membrane transporters of (highest to lowest potency) serotonin, dopamine and
norepinephrine [29]. In particular, blockade of the dopamine transporter by cocaine in utero
may affect development of dopaminergic mechanisms. Indeed, when the dopamine
transporter is not present during development (and beyond) in knockout mice, presynaptic
dopaminergic function is grossly altered: not surprisingly dopamine clearance is vastly
reduced, but dopamine content and release are also markedly decreased, and synthesis and
metabolism are increased [12].
Presynaptic function strongly influences dopaminergic neurotransmission. Dopamine is
synthesized from tyrosine in the cytosol of dopaminergic terminals. It can then be packaged
into small synaptic vesicles by the vesicular monoamine transporter or metabolized to 3,4-
dihyrox-yphenylacetic acid (DOPAC) and homovanillic acid (HVA) [14]. Some vesicles
bind to the cytoskeleton by actin filaments [28] to form a storage pool which can be
subsequently mobilized again by phosphorylation [32]. Mobile vesicles can dock to release
sites where they can be undocked to be mobile once again in the cytosol or their contents
can be released into the extracellular compartment by exocytosis [25]. Once dopamine
enters the extracellular space, it can interact with receptors until it is eventually removed by
the dopamine transporter [2]. If presynaptic D2-like terminal autoreceptors are activated
[27], further synthesis and secretion of dopamine is inhibited. The integration of all of these
processes ultimately determines the availability of dopamine for release. In addition, the
dopamine transporter regulates the time that it remains in the extracellular space.
The present study addresses whether there are long-lasting changes in presynaptic
dopaminergic function following prenatal exposure to cocaine that are present in adults and
could potentially contribute to behavioral abnormalities. This was assessed using fast-scan
cyclic voltammetry in brain slices and postmortem tissue content assessment from adult
male rats that had been prenatally exposed to cocaine or saline.
2. Methods
2.1. Animals
Virgin female (225–250 g) Sprague–Dawley rats (Charles River, Raleigh, NC, USA) were
group housed (rats per cage) during a two week habituation period. Rooms were on a 12-h
timed reverse light /dark cycle and animals had free access to rat chow (Purina) and water.
Females were bred and the morning a sperm plug was found was designated as gestational
day 0. Sperm positive females were removed and randomly assigned to one of two treatment
groups or as a surrogate and housed singly in plastic rat cages. The treatment groups
received subcutaneous injections of either 15 mg/kg of cocaine-HCl (Sigma, St. Louis, MO,
USA) in a normal (0.9%) saline solution or an equal volume of normal saline twice daily at
approximately 09:00 and 16:00 h from gestational days 1–20. Surrogates received no
treatment. Rat dams remained on the reverse light cycle for 8 days and were then housed in
a room with a normal 12-h light / dark cycle which results in most dams delivering in the
afternoon rather than the early morning (02:00–03:00 h). This procedure has been used in
several behavioral experiments and is more practical since we foster litters as soon as birth is
completed [21,22].
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Cocaine, saline and surrogate dams were fed ad libitum during pregnancy. Treatment dams
were weighed daily (surrogate dams were weighed every 3 days). Daily weight gain and any
unusual observations were recorded. Upon delivery, litters were weighed, and separated into
same sex litters of 10 male pups, one pup from each litter. Only one pup from any litter was
used in any group of experiments to control for litter effects. Pups were immediately given
to a surrogate dam that had delivered within 24 h of the cocaine or saline-treated dams. Pups
are transferred to the surrogate dams because we know that cocaine treatment can alter
maternal behavior towards the pups and we can control for differences resulting from
abnormal maternal behavior by cocaine-treated dams by fostering all pups to surrogates. In
this way biochemical differences can be assumed to be the result of the prenatal exposure
and not maternal behavioral differences.
2.2. Brain slices
Brain slices from adult progeny (postnatal day 180+) were prepared and maintained as
previously described [18]. Briefly, rats were sacrificed by decapitation and the brains rapidly
removed and cooled in ice-cold, pre-oxygenated (95% O2 /5% CO2) artificial cerebrospinal
fluid. The tissue was sectioned into 400-µm thick coronal slices containing the caudate
putamen or the nucleus accumbens, using a vibrotome (Vibroslice NVSL; World Precision
Instruments, Sarasota, FL, USA). Slices were kept in a reservoir of oxygenated artificial
cerebrospinal fluid at room temperature for up to 6 h until required. Thirty minutes before
each experiment, a brain slice was transferred to a ‘Scottish-type’ submersion recording
chamber [1], superfused at 1 ml /min with 34 °C oxygenated artificial cerebrospinal fluid,
and allowed to equilibrate. The artificial cerebrospinal fluid consisted of (in mM): NaCl
(126), KCl (2.5), NaH2PO4 (1.2), CaCl2 (2.4), MgCl2 (1.2), NaHCO3 (25), glucose (11),
HEPES (20) and was pH adjusted to 7.4.
Recordings were made either in the dorsolateral part of the caudate putamen or in the core of
the nucleus accumbens. A cylindrical carbon fiber microelectrode (7 µm diameter, ~100 µm
long) was inserted into the slice and a bipolar stimulating electrode (Plastics One, Roanoke,
VA, USA) was placed on the surface of the brain slice ~200 µm away. Extracellular
dopamine was monitored at the carbon fiber microelectrode every 100 ms using fast-scan
cyclic voltammetry [17] by applying a triangular waveform (−0.4 to + 1.0 V vs. Ag/AgCl,
300 V/s) using a biopotentiostat (EI400, Cypress Systems, Lawrence, KS, USA). Data were
digitized (National Instruments, Austin, TX, USA) and stored to a computer. Dopamine
release was evoked by single electrical pulses (±300 µA, 2 ms /phase) applied across the
stimulating electrode every 5 min. In some experiments, 20-pulse (50 Hz) stimulation trains
were also used to elicit dopamine release. In experiments where the absolute concentration
of dopamine was reported, three recording sites were used per slice to get a better estimate
of the population of dopamine release. So as not to introduce bias, the first three
implantations into the slice were used regardless of the release they yielded. In other
experiments, after a 30-min (six stimulation) stable baseline was achieved, cocaine (1 and 10
µM; Sigma, St. Louis, MO, USA) or quinpirole (0.001, 0.01, 0.1, 1 and 10 µM; Sigma) were
applied cumulatively (30 min per concentration) to the brain slice via the superfusant.
To assess the effects of these acute cocaine experiments, evoked levels of extracellular
dopamine were modeled as a balance between release and uptake [33]. The change in
dopamine concentration with respect to time was estimated by:
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where [DA] is the brain extracellular concentration of dopamine, [DA]p is the change in
concentration of dopamine at the electrode produced by each stimulus pulse, and Vmax and
Km are Michaelis–Menten rate constants for dopamine uptake.
2.3. Content studies
Animals were sacrificed by decapitation, and their brains rapidly removed. The caudate
putamen, nucleus accumbens and prefrontal cortex were dissected out and homogenized in
0.1 M HClO4 containing 100 ng/ml 3,4-dihydroxybenzylamine as an internal standard.
Homogenates were centrifuged for 10 min at 10 000 × g. Supernatants were filtered through
0.22-mm filters and analyzed using high performance liquid chromatography with
electrochemical detection. Samples (20 µl) were separated on a reverse-phase column (C18,
100 × 4.60 mm, Ultremex) with a mobile phase consisting of 50 mM monobasic sodium
phosphate, 0.2 mM octyl sodium sulfate, 0.1 mM EDTA, 10 mM NaCl and 10% methanol
(pH 2.6) at a flow rate of 1 ml /min. Dopamine, DOPAC, HVA, norepinephrine, serotonin
and 5-hyroxyindolacetic acid were detected by constant-potential amperometry (+0.65 V vs.
Ag/AgCl) at a glassy carbon electrode (BioAnalytical Systems).
2.4. Statistical analysis
All statistical analyses and sigmoid curve fitting were carried out using Prism® (GraphPad
Software, San Diego, CA, USA). Tissue content data were compared between prenatal
saline and prenatal cocaine-treated groups using unpaired t-tests. Other data were evaluated
by two-way analysis of variance.
3. Results
3.1. Gestational effects
There were no significant differences between cocaine-treated and control dams on
measures of dam weight gain, litter weight, number of male and female pups or number of
pups per litter.
3.2. Electrically evoked dopamine release
Electrical stimulation produced a transient increase in the extracellular dopamine
concentration (Fig. 1A). The rising phase is reciprocally controlled by dopamine release and
uptake, and the falling phase by uptake alone [33]. Consequently, the peak amplitude
([DA]max) is an index of the balance between release and uptake.
In dorsolateral caudate putamen, [DA]max following stimulation with a single electrical
pulse was 1.31 ± 0.20 µM (n = 12 recording sites from four animals) for prenatal saline and
1.06 ± 0.22 µM (n = 18 recording sites from six animals) for prenatal cocaine-treated rats
(mean ± s.e.m.; Fig. 1B). For stimulation with twenty electrical pulses (50 Hz), [DA]max was
approximately double that for a single pulse: 2.79 ± 0.61 µM (n = 12 recording sites from
four animals) for prenatal saline and 2.34 ± 0.49 µM (n = 12 recording sites from four
animals) for prenatal cocaine-treated rats (Fig. 1B). Statistical analysis (two-way analysis of
variance) revealed a main effect of stimulation pulses (F1,56 = 10.91, P < 0.01), but no effect
of treatment (F1,56 = 0.70, P > 0.05) or interaction between these (F1,56 = 0.05, P > 0.05).
In the nucleus accumbens, [DA]max for a single electrical pulse was 0.29 ± 0.08 µM for
prenatal saline and 0.28 ± 0.05 µM for prenatal cocaine-treated rats (P > 0.05; n = 12
recording sites from four animals; Fig. 1B) and about fourfold higher for twenty pulses: 1.18
± 0.28 µM for prenatal saline and 1.27 ± 0.16 µM for prenatal cocaine-treated rats (n = 12
recording sites from four animals; Fig. 1B). There was a main effect of stimulation pulses
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(F1,43 = 34.43, P < 0.0001), but no effect of treatment (F1,43 = 0.05, P > 0.05) or interaction
between these (F1,43 = 0.11, P > 0.05).
3.3. Acute cocaine challenge
To test dopamine uptake following acute cocaine challenge, cocaine was applied to brain
slices cumulatively at two concentrations (1 and 10 µM). In general, during application of 1
µM cocaine, there was an increase in the amplitude and duration of the extracellular
dopamine response to stimulation, and at 10 µM there was a further widening, but often a
decrease in the amplitude (Fig. 2A). Cocaine’s effects were further assessed by kinetic
analysis of these responses.
For baseline data, responses could be fitted well when Km was set to 0.16 µM (Fig. 2B), and
when Vmax was set to 4 µM/ s for the caudate putamen or 2 µM/ s for the nucleus
accumbens. In the caudate putamen, [DA]p was 1.68 ± 0.13 µM for prenatal saline and 1.78
± 0.45 µM for prenatal cocaine-treated rats (Fig. 2C). In the nucleus accumbens, it was 0.95
± 0.10 µM for prenatal saline and 0.85 ± 0.07 µM for prenatal cocaine-treated rats.
Cocaine’s effect was best fitted to an increase in the apparent Km without any change in
Vmax, consistent with competitive antagonism of the dopamine transporter. In addition,
[DA]p needed to be modified by a relatively small degree. In the caudate putamen, the
apparent Km increased more than 15-fold with 1-µM cocaine to 2.78 ± 0.46 µM in prenatal
saline and 2.51 ± 0.32 µM in prenatal cocaine-treated rats (Fig. 2B). With 10-µM cocaine, it
continued to increase to more than 50 times the predrug value, reaching 10.50 ± 1.94 µM
(prenatal saline) and 8.68 ± 1.40 µM (prenatal cocaine). Although this effect of acute
cocaine was highly significant (F2,9 = 45.37, P < 0.0001), there was no main effect of
prenatal treatment (F1,9 = 0.77, P > 0.05) nor was there an interaction (F2,9 = 0.46, P >
0.05). This effect of cocaine was paralleled in the nucleus accumbens where the apparent Km
increased to to 2.40 ± 0.55 µM in prenatal saline and 1.75 ± 0.30 µM in prenatal cocaine-
treated rats for 1 µM and to 10.05 ± 2.74 µM (prenatal saline) and 11.00 ± 2.12 µM
(prenatal cocaine) for 10-µM cocaine (Fig. 2B). Again, cocaine’s effect was significant (F2,9
= 25.08, P < 0.001) but prenatal treatment did not have a main effect (F1,9 = 0.01, P > 0.05)
or alter this response (F2,9 = 0.13, P > 0.05). To fit the effect of 1-µM cocaine, [DA]p was
increased to 2.07 ± 0.13 µM in the caudate putamen and 1.15 ± 0.17 µM in the nucleus
accumbens of prenatal saline rats, and to 2.10 ± 0.37 µM in the caudate putamen and 1.16 ±
0.15 µM in the nucleus accumbens of prenatal cocaine-treated rats (Fig. 2C). At 10-µM
cocaine, [DA]p dropped below the predrug value to 1.13 ± 0.16 µM (prenatal saline) and
1.29 ± 0.19 µM (prenatal cocaine) in the caudate putamen and 0.50 ± 0.11 µM (prenatal
saline) and 0.46 ± 0.07 µM (prenatal cocaine) in the nucleus accumbens. The effect of acute
cocaine on [DA]p was significant (F 2,9 = 8.65, P < 0.01, caudate putamen; F2,9 = 16.54, P <
0.001, nucleus accumbens), but once again, prenatal treatment had no effect (F1,9 = 0.13, P
> 0.05, caudate putamen; F1,9 = 0.18, P > 0.05, nucleus accumbens) nor interacted with
cocaine’s effect (F2,9 = 0.04, P > 0.05, caudate putamen; F2,9 = 0.11, P > 0.05, nucleus
accumbens). The decrease of [DA]p (seen in both prenatal treatment groups) at the higher
cocaine concentration has been observed previously [13]. This probably represents a
progressive depletion of dopamine due to the inability for it to be taken back up into
terminals while the dopamine transporter is blocked.
3.4. Dopamine autoinhibition
To test dopamine terminal autoreceptor function, the D2-like agonist, quinpirole, was
applied to brain slices at cumulative concentrations (1–10 000 nM). Quinpirole produced
concentration-dependent inhibitions of [DA]max for single pulse electrical stimulation that
could be fitted by a sigmoid curve when plotted as a semilog graph (R2 = 0.99; Fig. 3).
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During curve-fitting Hill slopes were fixed to a standard slope factor (1.0). This was
justified because if they were fitted, values of 1.15 ± 0.15 (prenatal saline) and 0.92 ± 0.10
(prenatal cocaine) in the caudate putamen and 0.99 ± 0.03 (prenatal saline) and 1.02 ± 0.11
(prenatal cocaine) in the nucleus accumbens were obtained. The bottom of the slopes (i.e.
response for no quinpirole) were fixed to the pre-quinpirole value (100%).
In dorsolateral caudate putamen, quinpirole produced a maximum inhibition of [DA]max of
73.2 ± 3.5% in prenatal saline and 78.0 ± 1.0% in prenatal cocaine-treated rats (n = 4). The
log-concentration that extrapolated to the half-maximal response (log EC50) was −6.95 ±
0.11 (112 nM) for prenatal saline and −6.95 ± 0.03 (112 nM) for prenatal cocaine-treated
rats. In the nucleus accumbens, quinpirole produced a maximum inhibition of [DA]max of
83.4 ± 3.4% in prenatal saline and 87.6 ± 0.9% in prenatal cocaine-treated rats (n = 4). The
log EC50 was −7.63 ± 0.11 (23.7 nM) for prenatal saline and −7.64 ± 0.03 (23.1 nM) for
prenatal cocaine-treated rats. Quinpirole was highly effective at inhibiting dopamine release
(F4,30 = 54.13, P < 0.0001, caudate putamen; F4,30 = 84.16, P < 0.0001, nucleus
accumbens), but prenatal treatment had no significant effect (F1,30 = 0.03, P > 0.05, caudate
putamen; F1,30 = 0.10, P > 0.05, nucleus accumbens) or interaction (F4,30 = 0.30, P > 0.05,
caudate putamen; F4,30 = 0.57, P > 0.05, nucleus accumbens) with this. In addition, there
were no significant differences between treatment groups in the extrapolated maximal
response for quinpirole or its EC50 in either region (P > 0.05, unpaired t-test).
3.5. Tissue content
Tissue levels of dopamine and its metabolites DOPAC and HVA were measured in the
caudate putamen and nucleus accumbens (Fig. 4).
In the caudate putamen, there was 93.7 ± 1.8 pmol/mg of dopamine, 10.8 ± 0.5 pmol/mg of
DOPAC and 3.40 ± 0.22 pmol/mg of HVA in prenatal saline and 69.0 ± 8.2 pmol/mg of
dopamine, 8.27 ± 0.95 pmol/mg of DOPAC and 2.69 ± 0.28 pmol/mg of HVA in prenatal
cocaine-treated rats (n = 5). These levels of dopamine and DOPAC were significantly lower
in prenatal cocaine-treated rats (P < 0.05), but there was no significant difference for HVA
(P > 0.05).
In the nucleus accumbens, there was 54.5 ± 0.47 pmol/ mg of dopamine, 12.0 ± 1.6 pmol/
mg of DOPAC and 2.80 ± 0.16 pmol/mg of HVA in prenatal saline and 43.8 ± 4.6 pmol/mg
of dopamine, 8.63 ± 0.77 pmol/mg of DOPAC and 2.03 ± 0.33 pmol/mg of HVA in prenatal
cocaine-treated rats (n = 5). There was no significant difference in these levels between
prenatal treatment groups (P > 0.05).
Tissue levels were also measured in the prefrontal cortex where there was no significant
difference in dopamine (DOPAC and HVA were undetectable) between the prenatal
treatment groups (P > 0.05; data not shown). In addition, levels of serotonin, 5-
hyroxyindolacetic acid and norepinephrine were measured and were no different between
treatment groups in any of the nuclei (P > 0.05; data not shown).
4. Discussion
In this study we tested the hypothesis that prenatal cocaine exposure modifies presynaptic
dopamine function in adult male rats. The dopaminergic response to single pulse electrical
stimulation was no different between prenatal treatment groups in either the caudate
putamen or the nucleus accumbens. The peak amplitude is determined by the balance
between release and uptake, and therefore this balance does not appear to be altered by
prenatal cocaine exposure. This could be either because release and uptake are both
unaltered or they have changed in parallel. For stimulation trains, the dependence of
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[DA]max on uptake is greater than for single pulse stimulations. This is because in addition
to affecting the amplitude of the individual peak response for each impulse uptake
exclusively controls extracellular dopamine concentration between pulses, and therefore
determines the extent of summation of the response to individual pulses. For stimulus trains,
there was also no difference in [DA]max between prenatal treatment groups. Together these
data suggest that there is not a parallel change in release and uptake, and that neither
parameter is altered by prenatal cocaine treatment. Furthermore, when evoked responses
were modeled, release ([DA]p) and uptake (Km and Vmax) parameters were also no different
in rats that received prenatal cocaine or saline, further corroborating that release and uptake
are unaltered. The release parameter measured here is evoked and therefore solely reflects
presynaptic mechanisms rather than incorporating effects of action potential traffic. This
parameter is controlled by the amount of dopamine in the synaptic vesicles, influenced by
dopamine biosynthesis and the vesicular monoamine transporter, and the number of vesicles
released per impulse, influenced by vesicle trafficking mechanisms and exocytosis. The
present data suggest that all of these mechanisms remain intact in male adult rats that were
prenatally exposed to cocaine.
The effect of acute cocaine challenge was not different between prenatal treatment groups in
either the caudate putamen or the nucleus accumbens. This once again indicates that uptake
is normal following prenatal cocaine exposure, and also suggests that the dopamine
transporter does not have altered sensitivity to cocaine. Interestingly, in a whole animal
study, the dopaminergic response to systemic cocaine challenge was enhanced in the nucleus
accumbens of adult rats that were exposed to cocaine in utero [15]. The brain slice
preparation is reductionist: the isolated dopaminergic terminals are devoid of impulse traffic
and control by tonic releasing agents [8] such as glutamate, narrowing the number of
pharmacological targets. Since this reductionism removes sensitization to acute challenge
with cocaine, it alludes to targets of the sensitization. The key pharmacological target for
cocaine regulating the evoked extracellular dopamine response in the brain slice preparation
is the dopamine transporter on dopaminergic terminals. The present data clearly
demonstrates that this is not the target of the sensitization seen by others. Thus, it must be
regulated at another level such as dopaminergic cell firing and/or serotonergic mechanisms.
Prenatal exposure to cocaine also did not alter the action of the D2-like agonist, quinpirole
on dopamine release in the male adult. This suggests that release- and synthesis regulating
autoreceptors function normally, and are not altered in number by prenatal cocaine
treatment. Consistent with this, it was reported that neither D2 binding nor mRNA levels are
altered in the striatum of adults rats that were prenatally exposed to cocaine [31]. However,
another study observed a 20% decrease in the maximum ligand binding at D2 receptors for
180 day old, prenatal cocaine-exposed male [9]. In light of our findings, it would seem that
any effect must be limited to changes in a subpopulation of postsynaptic D2 receptors, (since
the presynaptic D2 receptors remain functionally intact).
In rats that received cocaine prenatally, the content of dopamine was significantly reduced in
the caudate putamen, with a similar, but non-significant trend in the nucleus accumbens.
This is consistent with reduced dopamine response to amphetamine challenge beyond
postnatal day 80 as reported by others in prenatal cocaine-exposed male rats [7,26,30].
Terminal dopamine content could be decreased if its metabolism by monoamine oxidase in
the cytosol was increased, but since levels of DOPAC (the metabolic product) were also
decreased, this is unlikely to be the case. Dopamine levels could also be reduced if its
utilization was increased. We have shown in the present study that release mechanisms
function normally in adult rats prenatally exposed to cocaine. Therefore a net increase in
release could only come about by an increase in the rate of its triggering i.e. increased
impulse traffic to the terminal and/or tone of releasing agents such as glutamate. However, if
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this were the case, there would be an increase in the outflow of dopamine to the extracellular
space. Keller and colleagues [15,16] have shown that extracellular levels of adult rats
prenatally exposed to cocaine are normal in both the caudate putamen [16] and the nucleus
accumbens [15]. These measurements provide information on the net balance between the
maintained outflow of dopamine (release) and its clearance. The predominant mechanism
for clearance of extracellular dopamine is uptake into dopaminergic terminals via the
dopamine transporter [2,5], and in the present study, we demonstrated that this is unaltered.
Therefore it follows that the maintained release must also be unchanged in rats prenatally
exposed to cocaine. Uptake of dopamine into terminals also provides a source of
intracellular dopamine, and since it is unaltered, this also cannot account for the decreased
dopamine levels. Dopamine biosynthesis could be reduced, but this would cause a decrease
in electrically evoked dopamine release that was not observed in the present study.
Furthermore, since the terminal operates at equilibrium, the production of dopamine must
balance the consumption. The data presented here and in the literature suggest that the
consumption of dopamine is not altered suggesting that dopamine synthesis should also be
unaltered. Since the content of dopamine in the terminals mainly reflects storage pools of
dopamine [19], this leaves the possibility that the amount of stored dopamine (bound to the
cytoskeleton) is decreased. However, this effect should not alter dopaminergic function
other than during extreme challenge (e.g. with amphetamine) or dopamine depletion.
In summary, we report that presynaptic dopaminergic function remains largely intact in
adult, male rats that were prenatally exposed to cocaine. The ability for terminals in the
caudate putamen and nucleus accumbens to release and regulate dopamine is unaltered.
However the tissue content of dopamine in the caudate putamen was decreased, representing
a diminution in the dopamine storage pool. We conclude that behavioral abnormalities
observed in adults that were exposed to cocaine in utero are not mediated through
presynaptic dopaminergic mechanisms in mesolimbic or mesostriatal neurons. These effects
possibly arise because of changes in the serotonergic or noradrenergic systems following
prenatal cocaine exposure.
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Dopamine release evoked by electrical stimulation. (A) Representative neurochemical
responses in the dorsolateral caudate putamen to local electrical stimulation (single biphasic
pulse, ± 300 µA, 2 ms /phase). Following the stimulation (indicated by the arrow), there is a
rise in extracellular dopamine, followed by a decrease back to baseline. Each point
represents a measurement of dopamine concentration from one voltammetric scan taken
every 100 ms. The right panel shows a background-subtracted cyclic voltammogram taken
at the peak response to the stimulus. The x-axis of this represents the applied potential (vs.
Ag/AgCl) and the y-axis represents the faradaic current yielded during a single voltammetric
scan. The voltammogram provides chemical information on the analyte: it has an oxidation
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peak (negative current) at applied potential +0.6 V and reduction peak (positive current) at
−0.2 V, characteristic of dopamine. (B) The peak extracellular dopamine concentration
([DA]max) following a single electrical pulse or a train of twenty pulses (50 Hz) in the
dorsolateral caudate putamen (left) or the core of the nucleus accumbens (right). Responses
for prenatal cocaine-treated rats are represented by the solid bars and for saline-treated rats
by the open bars. Prenatal treatment with cocaine did not alter the responses to electrical
stimulation (caudate putamen: F1,56 = 0.05, P > 0.05; nucleus accumbens: F1,43 = 0.11, P >
0.05; two-way analysis of variance, n = 12–18).
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Effect of acute cocaine treatment. (A) Representative responses to 0- (left), 1- (middle) or
10-µM (right) cocaine in the dorsolateral caudate putamen. Following electrical stimulation
(single biphasic pulse, ±300 µA, 2 ms / phase; indicated by the arrow), there is a rise in
extracellular dopamine, followed by a decrease back to baseline. Each point represents a
measurement of dopamine concentration from one voltammetric scan taken every 100 ms.
The solid lines are fitted kinetic analyses of the responses. The insets show background-
subtracted cyclic voltammograms taken at the peak response to the stimulus. The x-axis of
this represents the applied potential (vs Ag/AgCl) and the y-axis represents the faradaic
current yielded during a single voltammetric scan. The voltammogram provides chemical
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information on the analyte: it has an oxidation peak (negative current) at applied potential
+0.6 V and reduction peak (positive current) at −0.2 V, characteristic of dopamine. (B) The
effect of cocaine on the apparent Michaelis–Menten rate constant for uptake (Km) in the
dorsolateral caudate putamen (left) and the core of the nucleus accumbens (right). Responses
for prenatal cocaine-treated rats are represented by the solid bars and for saline-treated rats
by the open bars. Prenatal treatment with cocaine did not alter the acute effects of cocaine on
Km (caudate putamen: F2,9 = 0.46, P > 0.05; nucleus accumbens: F2,9 = 0.13, P > 0.05; two-
way analysis of variance, n=4). (C) The effect of cocaine on the change in dopamine
concentration at the electrode produced by each stimulus pulse ([DA]p) in the dorsolateral
caudate putamen (left) and the core of the nucleus accumbens (right). Responses for prenatal
cocaine-treated rats are represented by the solid bars and for saline-treated rats by the open
bars. Prenatal treatment with cocaine did not alter the acute effects of cocaine on [DA]p
(caudate putamen: F2,9 = 0.04, P > 0.05; nucleus accumbens: F2,9 = 0.11, P > 0.05; two-way
analysis of variance, n=4).
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Autoreceptor function. The graphs show cumulative semilog plots of the effect of quinpirole
on the peak extracellular dopamine concentration ([DA]max) following a single-pulse
electrical stimulation (biphasic pulse, ± 300 µA, 2 ms/phase) in the caudate putamen (left) or
the core of the nucleus accumbens (right). Responses for prenatal cocaine-treated rats are
represented by the solid symbols and for saline-treated rats by the open symbols. The lines
are best-fit sigmoid curves (R2 = 0.99). Prenatal treatment with cocaine did not alter the
effect of quinpirole on dopamine inhibition (caudate putamen: F4,30 = 0.30, P > 0.05;
nucleus accumbens: F4,30 = 0.57, P > 0.05; two-way analysis of variance, n=4).
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Tissue content of dopamine, 3,4-dihyroxyphenylacetic acid (DOPAC) and homovanillic acid
(HVA) in the caudate putamen (left) and the core of the nucleus accumbens (right). Levels
for prenatal cocaine-treated rats are represented by the solid bars and for saline-treated rats
by the open bars. * P < 0.05 vs. saline-treated control, unpaired t-test (n=5).
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